The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $58.19

Today's change+1.27 +2.23%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $58.19

Today's change+1.27 +2.23%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

Neogen Corp up sharply

Neogen Corp closed up sharply Friday, rallying (U.S.)$1.27 or 2.23% to (U.S.)$58.19. Over the last five days, shares have gained 1.15% and 17.34% year to date. Shares have outperformed the S&P 500 by 24.31% during the last year.

Key company metrics

  • Open(U.S.) $57.05
  • Previous close(U.S.) $56.92
  • High(U.S.) $58.66
  • Low(U.S.) $56.95
  • Bid / Ask-- / --
  • YTD % change+17.34%
  • Volume224,892
  • Average volume (10-day)398,884
  • Average volume (1-month)260,064
  • Average volume (3-month)180,309
  • 52-week range(U.S.) $38.74 to (U.S.) $62.70
  • Beta1.16
  • Trailing P/E64.84×
  • P/E 1 year forward52.29×
  • Forward PEG3.42×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.90
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.86%

Based on its net profit margin of 11.86%, Neogen Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMay 31, 201505/31/2015Feb 28, 201502/28/2015Nov 30, 201411/30/2014Aug 31, 201408/31/2014
Revenue79686868
Total other revenue--------
Total revenue79686868
Gross profit38343434
Total cost of revenue41353434
Total operating expense64565654
Selling / general / administrative21191918
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income15121313
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax14121214
Income after tax9789
Income tax, total5455
Net income9789
Total adjustments to net income--------
Net income before extra. items9789
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9789
Inc. avail. to common incl. extra. items9789
Diluted net income9889
Dilution adjustment--00--
Diluted weighted average shares38383737
Diluted EPS excluding extraordinary itemsvalue per share0.250.200.210.24
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.250.200.210.24